Developing lithium chemistry of 1,2-dihydropyridines : from kinetic intermediates to isolable characterized compounds by Armstrong, David R. et al.
Strathprints Institutional Repository
Armstrong, David R. and Harris, Catriona M. M. and Kennedy, Alan R. 
and Liggat, John J. and McLellan, Ross and Mulvey, Robert E. and 
Urquhart, Matthew D. T. and Robertson, Stuart D. (2015) Developing 
lithium chemistry of 1,2-dihydropyridines : from kinetic intermediates to 
isolable characterized compounds. Chemistry - A European Journal, 21 
(41). pp. 14410-14420. ISSN 0947-6539 , 
http://dx.doi.org/10.1002/chem.201501880
This version is available at http://strathprints.strath.ac.uk/54112/
Strathprints is  designed  to  allow  users  to  access  the  research  output  of  the  University  of 
Strathclyde. Unless otherwise explicitly stated on the manuscript, Copyright © and Moral Rights 
for the papers on this site are retained by the individual authors and/or other copyright owners. 
Please check the manuscript for details of any other licences that may have been applied. You 
may  not  engage  in  further  distribution  of  the  material  for  any  profitmaking  activities  or  any 
commercial gain. You may freely distribute both the url (http://strathprints.strath.ac.uk/) and the 
content of this paper for research or private study, educational, or not-for-profit purposes without 
prior permission or charge. 
Any  correspondence  concerning  this  service  should  be  sent  to  Strathprints  administrator: 
strathprints@strath.ac.uk
Developing Lithium Chemistry of 1,2-Dihydropyridines: From 
Kinetic Intermediates to Isolable Characterized Compounds 
David R. Armstrong, Catriona M. M. Harris, Alan R. Kennedy, John J. Liggat, Ross 
McLellan, Robert E. Mulvey,* Matthew D. T. Urquhart and Stuart D. Robertson* 
WestCHEM, Department of Pure and Applied Chemistry, University of Strathclyde, 
Glasgow, G1 1XL, UK. 
stuart.d.robertson@strath.ac.uk; r.e.mulvey@strath.ac.uk  
Dr. David R. Armstrong, Catriona M. M. Harris, Dr. Alan R. Kennedy, Dr. John J. 
Liggat, Dr. Ross McLellan, Prof. Robert E. Mulvey,* Matthew D. T. Urquhart and Dr. 
Stuart D. Robertson* 
 
Dedicated to Professor Manfred Scheer on the happy occasion of his 60th birthday 
Abstract 
Generally considered kinetic intermediates in addition reactions of alkyllithiums to 
pyridine, 1-lithio-2-alkyl-1,2-dihydropyridines have been rarely isolated or 
characterized. This study develops their ³LVRODWHG´ FKHPLVWU\. By a unique 
stoichiometric (that is 1:1, alkyllithium:pyridine ratios) synthetic approach using 
tridentate donors we show it is possible to stabilize and hence crystallize monomeric 
complexes where alkyl is t-butyl. Theoretical calculations probing the donor-free 
parent t-butyl species reveal 12 energetically similar stereoisomers in two distinct 
cyclotrimeric (LiN)3 conformations. NMR studies (including DOSY spectra) and 
thermal volatility analysis compare new s-butyl and i-butyl isomers showing the 
former is a hexane soluble efficient hydrolithiation agent converting benzophenone to 
lithium diphenylmethoxide. Emphasizing the criticalness of stoichiometry, reaction of 
nBuLi/Me6TREN with two equivalents of pyridine results in non-alkylated 1-lithio-
1,4-dihydropyridine·Me6TREN and 2-n-butylpyridine, implying mechanistically the 
kinetic 1,2-n-butyl intermediate hydrolithiates the second pyridine.  
 
Introduction 
The dihydropyridyl unit 1 is prevalent in both biological 2 and medicinal chemistry 3 
as a transfer hydrogenation (reduction) agent. In the former case this takes the form of 
naturally occurring nicotinamide adenine dinucleotide (NADH) or its phosphorylated 
derivative NADPH (figure 1), which act as cofactors for mediating redox processes 
such as photosynthesis. In the latter case, Hantzsch esters (figure 1) can be utilized as 
calcium antagonists to treat hypertension (high blood pressure). Dihydropyridyl units 
have also been comprehensively studied in organic chemistry for asymmetric transfer 
hydrogenation purposes 4 as well as for pyridine functionalization.5  
 
Figure 1 ChemDRAW representations of structures of biochemically relevant 
dihydropyridyl containing compounds 
 
The driving force behind the utility of dihydropyridyl systems is the rearomatization 
of the ring to give an aromatic pyridine derivative. In both of the cases depicted in 
figure 1 the reactive species has been identified as the 1,4-dihydropyridyl isomer. 
Closely related to this work, the N-metallo dihydropyridyls, with greater negative 
charge, would appear to be ideal hydrometallation reagents operating under the same 
principles with a rearomatization engine driving their reductive capability. This logic 
has indeed been proved correct ZLWKIRUH[DPSOH/DQVEXU\¶VUHDJHQW6 generated from 
lithium aluminum hydride LiAlH4 and excess pyridine and formulated as the 
pyridine-solvent-separated ion pair [Li(NC5H5)4]+ [Al(1,4-NC5H6)4]¯ (figure 2, top),7 
which acts as a selective reducing agent for aldehyde or ketone functionalities in the 
presence of carboxylic acid or ester groups. This 1-aluminato-1,4-dihydropyridyl 
complex (along with other related metallo-1,4-dihydropyridyl complexes including 
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those of lithium,8 magnesium,9 zinc9a, 10 and other aluminium complexes 11) is 
generally accepted as being the thermodynamically controlled isomer with the kinetic 
intermediate being a 1,2-dihydropyridyl isomer, leaving only limited synthetic access 
to the 1,2-isomer.12 1-Metallo-1,2-dihydropyridines have been implicated as the 
active intermediates in the metal catalyzed 1,2-hydroboration of pyridine,13 while the 
presence of a metal salt such as a zinc or magnesium dihalide is known to activate the 
reduction of unactivated ketones and aldehydes by 1-methyl-1,4-dihydropyridines.14 
 
Figure 2 &KHP'5$:UHSUHVHQWDWLRQRIPROHFXODUVWUXFWXUHRI/DQVEXU\¶VUHDJHQW
and general synthetic protocol for preparation of 1-lithio-2-butyl-1,2-dihydropyridines  
 
The addition of metal-carbon bonds to pyridines gives either the 1,2- or 1,4-addition 
product (e.g., organoanion = allyl, M = K;15 K/Zn;15 Ca;16 Al 17). Steric blocking at 
the 2 and 6 positions of the pyridine ring for example with imino substituents, does 
not necessarily promote 1,4 addition.18 A ring substituent may be susceptible to 
deprotonative attack if it contains hydrogen atoms which are sufficiently inductively 
acidified by the pyridyl ring, for example a methyl group, as in picoline.16, 19 
Recently, we revisited the well known 1,2-nucleophilic addition reaction of alkyl 
lithium reagents to pyridine,20 albeit by employing a stoichiometric volume of 
pyridine rather than the typical excess (figure 2, bottom).21 This new approach 
allowed us to isolate and characterize some pure 1-lithio-2-alkyl-1,2-dihydropyridine 
(2-nBuC5H5NLi, 1, figure 2 bottom) complexes (that is suspected kinetic 
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intermediates), normally utilized in situ for the purpose of pyridine functionalization, 
which somewhat surprisingly were thermally robust and in the case of the t-butyl 
example 2-tBuC5H5NLi (1t) was hexane soluble. This solubility, which was attributed 
to the steric effect of the t-butyl arm alpha to the N-Li bond and its consequent 
molecular constitution since in contrast the n-butyl isomer 2-nBuC5H5NLi (1n) is a 
hexane-insoluble polymer, makes it an excellent LiH surrogate complex, as 
exemplified by its hydrolithiation of benzophenone.22 Practical soluble sources of 
alkali-metal hydrides are coveted with only a select few examples reported.23 
Furthermore it was possible to characterize this 1,2-dihydropyridyl complex 
crystallographically as a monomer, presumably a more reactive form than an 
aggregated type, by coordinatively saturating the lithium with a polydentate neutral 
donor in 2-tBuC5H5NLi·Me6TREN, 1t·Me6TREN. We have now extended this work 
here to look at both cheaper, commercially available polydentate donors for similar 
monomer stabilization and also synthetically safer alkyl lithium reagents in the pursuit 
of alternative soluble sources of lithium hydride. Their solubility, thermal robustness 
and utility as hydrolithiation reagents have been appraised. The importance of 
utilizing stoichiometric pyridine in the pursuit of a 1,2-dihydropyridyl complex is also 
emphasized by our findings. All complexes have been compared in solution by 
multinuclear NMR spectroscopy and in the solid state by X-ray crystallography where 
possible, while a theoretical study of the trimeric complex 1t has also been carried out. 
Results and Discussion 
Donor stabilized monomers of 1-lithio-2-t-butyl-1,2-dihydropyridine 
Noting the incomplete K3 coordination of tetradentate Me6TREN to lithium in 
1t·Me6TREN, we began by studying more readily available tridentate ligands in its 
place for oligomer to monomer deaggregation and stabilization. Although Me6TREN 
has a proven record for stabilizing sensitive monomers,24 it is time-consuming to 
prepare and expensive to purchase commercially (£111/mL),25 meaning that a 
commercially available, cheaper alternative would be more practical and economical. 
To explore this possibility experimentally, equimolar amounts of commercially 
available PMDETA (N,N,1¶,1¶¶,1¶¶-pentamethyldiethylenetriamine, 24p/mL)25 and 
Me4AEE (bis-[2-(N,N-dimethylamino)ethyl]ether, 23p/mL)25 were introduced to a 
yellow hexane solution of 1t and cooled in a freezer to afford crystalline complexes 
identified by X-ray crystallographic analyses as monomeric 2-tBuC5H5NLi·PMDETA 
(1t·PMDETA) and 2-tBuC5H5NLi·Me4AEE (1t·Me4AEE) respectively (figure 3). 
Only the former crystal structure determination was of sufficient quality to discuss 
bond parameters although the latter unambiguously confirms the molecular 
connectivity and oligomerization state. In each case the structure is mononuclear, with 
the tBu group and one donor atom lying below the plane of the pyridyl ring and the 
other two donor atoms lying above to minimize steric repulsion (see figure 2, right 
hand side).  
 
 
 
Figure 3 Molecular structure of 2-tBuC5H5NLi·PMDETA (1t·PMDETA, top) and 2-
tBuC5H5NLi·Me4AEE (1t·Me4AEE, bottom). Ellipsoids are displayed at 50% 
probability and all hydrogen atoms except that on the saturated C5 of the 
dihydropyridyl ring are omitted for clarity.  
 Table 1 Selected bond lengths (Å) and angles (o) for complexes 1t·PMDETA and 
1t·Me6TREN21 
 1t·PMDETA 1t·Me6TREN  1t·PMDETA 1t·Me6TREN 
Li1-N1 1.976(2) 1.971(2) N1-Li1-
N2 
122.4(1) 120.6(1) 
Li1-N2 2.153(2) 2.137(2) N1-Li1-
N3 
123.4(1) 125.4(1) 
Li1-N3 2.180(2) 2.197(3) N1-Li1-
N4 
115.1(1) 114.9(1) 
Li1-N4 2.194(3) 2.178(3) N2-Li1-
N3 
84.6(1) 84.9(1) 
N1-C1 1.332(2) 1.336(2) N2-Li1-
N4 
116.7(1) 117.8(1) 
C1-C2 1.379(2) 1.378(2) N3-Li1-
N4 
85.2(1) 85.0(1) 
C2-C3 1.421(2) 1.424(2)    
C3-C4 1.345(2) 1.341(2)    
C4-C5 1.516(2) 1.510(2)    
C5-N1 1.483(2) 1.479(2)    
 
Comparison of the pertinent bond parameters presented in table 1 confirms that the 
bonding between the polydentate donor and lithium-dihydropyridyl moiety is very 
similar in each case and that as with Me6TREN, the three N donor atoms of PMDETA 
are sufficient for stabilization of the reactive monomer. In particular, the conjugated 
double bond system is evident by the alternating short and long bonds in the C1-C2-
C3-C4-C5 unit [1.378(2)/1.424(2)/1.341(2)/1.510(2) Å] while C5 is again clearly sp3 
hybridized with a distorted tetrahedral coordination sphere, lying 0.387(1) Å 
outside of the mean plane of the C1=C2-C3=C4 unit. 
The 1H and 13C NMR spectra of 1t·PMDETA in C6D12 solution closely resemble 
those of 1t·Me6TREN with all corresponding resonances appearing within 0.1 
ppm (1H) or 1 ppm (13C, table 2), which may be expected given the close 
similarities between their molecular structures. The 7Li resonances and their half 
height line widths are virtually identical at 0.81 (5.94 Hz) and 0.82 (6.09 Hz) 
ppm. On moving to 1t·Me4AEE, there is a more pronounced shielding of the 
H2/C2 resonances (3.46/66.9 ppm; cf 3.54/69.5 and 3.62/69.0 ppm for PMDETA 
and Me6TREN solvates respectively) and also a deshielding of the H3/C3 
(4.18/97.2, cf 3.95/95.2; 4.03/95.7) and H5/C5 resonances (4.36/91.6, cf 
4.07/87.4; 4.09/88.2) with respect to the N x 3 donor solvated derivatives, most 
likely as a consequence of changing one of the Lewis donating atoms to more 
electronegative oxygen which will in turn subtly alter the electronics of the 
dihydropyridyl ring. Likewise, the 7Li resonance is noticeably shifted to 0.34 ppm 
(cf 1t·Me6TREN, 0.81 ppm).  
Table 2 Comparison of 1H, 13C and 7Li NMR spectroscopic data for solvated complexes of 1t in C6D12 solution, of unsolvated complexes 1t and 
1s in C6D12 solution, and of complexes 1n and 1i in d8-THF solution.  
 
1t·Me6TREN21 1t·PMDETA 1t·Me4AEE 1t·TMEDA 1t21 1s 1n21 1i 
H2/C2 3.62/69.0 3.54/69.5 3.46/66.9 3.30/66.2 3.12/66.1 3.10/60.6 3.54/57.6 3.63/53.3 
H3/C3 4.03/95.7 3.95/95.2 4.18/97.2 4.07/94.4 4.37/95.1 4.40/95.1 4.08/96.7 3.97/95.1 
H4/C4 5.88/128.7 5.85/128.8 5.92/128.2 6.04/127.0 6.12/127.9 6.04/125.7 5.72/126.4 5.71/126.5 
H5/C5 4.09/88.2 4.07/87.4 4.36/91.6 4.58/93.8 4.92/95.1 5.08/96.6 4.29/90.0 4.25/89.2 
H6/C6 6.53/151.1 6.56/150.8 6.62/151.0 6.71/151.3 6.85/150.0 6.73/147.7 6.55/150.0 6.54/150.0 
Quaternary C 42.1 41.1 40.9 41.6 39.3 - - - 
tBu (H/C) 0.86/25.4 0.87/25.7 0.84/25.7 0.82/26.0 0.83/25.6 - - - 
Li  0.81 0.82 0.34 -1.67 -1.79 -1.97 2.17 0.29 
  
Next we turned to the common and inexpensive bifunctional donor N,N,1¶,1¶-
tetramethylethylenediamine (TMEDA, 11p/mL),25 which when added to 1t in hexane 
and cooled, afforded a non X-ray quality crystalline product [2-
tBuC5H5NLi·TMEDA]2. 
 
Figure 4 Proposed molecular structure of complex [2-tBuC5H5NLi·TMEDA]2, 
1t·TMEDA. 
 
1H and 13C NMR analysis of 1t·TMEDA in C6D12 solution unequivocally confirmed 
the regioselective 1,2 alkyllithium addition to pyridine and that the resulting 
dihydropyridyl:TMEDA ratio was 1:1. The 1H NMR spectroscopic resonances of the 
ring hydrogen atoms appeared at values intermediate between those of monomeric, N-
solvated complexes 1t·Me6TREN and 1t·PMDETA and of unsolvated trimeric 
complex 1t (for example H5 resonates at 4.58 ppm in 1t·TMEDA, cf 4.07 in 
1t·PMDETA and 4.92 in 1t; see table 2 for full details), perhaps suggesting an 
intermediate aggregation scenario (that is, dimeric as postulated in figure 4: a 
common bonding scenario seen previously in TMEDA solvated lithium amides,26 
including those formed through the alpha metalation of functionalized pyridines27) 
although this could also be due to the fewer number of Lewis basic nitrogen atoms 
solvating the lithium atom. Cooling of a d14-hexane solution of 1t·TMEDA to -70oC 
resulted in a broadening of the TMEDA resonances but no splitting of them, meaning 
we were unable to infer whether the dimer adopts a cisoid or transoid conformation 
with respect to the two tBu groups (that is C2v or C2h symmetry) in the manner 
described previously by Harder.28 
In the absence of a solid state structure for 1t·TMEDA, we turned to a 1H DOSY 
NMR spectroscopy study,29 (which has been used effectively in organometallic 
chemistry for solution state molecular weight determination30), again in C6D12, to 
estimate its aggregation state (n) in solution of [2-tBuC5H5NLi·TMEDA]n, the results 
of which suggested an estimated molecular weight of 420 at 0.2 mol L-1 (refer to SI 
for details). This value lies intermediate between the calculated molecular weights of 
a monomer (n = 1; 259) and dimer (n = 2; 518). While considerably removed from 
either value, this result is possibly indicative of a dimer in solution as it has 
previously been noted31 that coordinated Lewis donors can undergo a rapid 
coordination/decoordination event (equation 1) which can be seen on the DOSY 
NMR timescale, resulting in an estimated molecular weight value intermediate 
between the solvated (518) and unsolvated (286) aggregate. Typically, further 
evidence for this is an estimated molecular weight for the coordinating Lewis donor 
lower than that of the complex but higher than that of the free Lewis donor itself. In 
this example we note the estimated molecular weight for TMEDA as calculated using 
the resonances at 2.25 and 2.34 ppm is 169 (TMEDA itself has a significantly lower 
molecular weight of 116). 
 
We considered a second hypothesis for this DOSY result, namely that a complex of 
formula [2-tBuC5H5NLi]2·TMEDA is present in solution, that is an asymmetric 
structure in which only one of the lithium cations is solvated by TMEDA (such a 
complex would have a molecular weight of 402, much closer to the experimentally 
determined MWDOSY, < 5% error). Asymmetrically mono-solvated dinuclear alkali-
metal amides have been crystallographically characterized previously, for example 
the THF-solvated sodium 1,1,1,3,3,3-hexamethyldisilazide 32 or the TMEDA-solvated 
heterometallic lithium/sodium 2,2,6,6-tetramethylpiperidide.33 However, we consider 
this reduced solvation to be unlikely in this instance since the tBuC5H5N:TMEDA 
ratio is unity as determined by integration of the 1H NMR spectrum.  
 
Theoretical calculations on oligomeric 2-tBuC5H5NLi 
[2-tBuC5H5NLiTMEDA]2 [2-tBuC5H5NLi]2 + 2 TMEDA
(518) (286) (116)
eq. 1
Having postulated that unsolvated complex 1t is a cyclotrimer, we turned to DFT 
calculations using the B3LYP density functional and 6-311(d, p) basis set, to probe if 
such oligomerization is reasonable. Such a motif is well-documented in structural 
lithium amide chemistry,34 including the synthetically important utility amides35 
LiHMDS36 and LiTMP.37 Because of the tetrahedral nature of the nitrogen atoms we 
modeled two distinct ring types, namely those with the tBu groups on the same side of 
the ring (type A, figure 5a) or those with two on one side and one on the other (type B, 
figure 5a). The calculations revealed that the dihydropyridyl rings did not lie perfectly 
perpendicular to the Li3N3 plane but rather tilted towards one of the neighboring 
lithium atoms due to a slight interaction of theS electron density with the Lewis 
acidic lithium neighbor. This resulted in a shorter (V-bonded) neighbor and a longer 
(S-bonded) neighbor (illustrated through single and dashed lines respectively in figure 
5b) giving axial chirality and meaning that the S,S,S system (entry 1) is not the same 
as the R,R,R system (entry 4) as might have been thought originally. Table 3 
summarizes the findings of this study.  
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Figure 5 a) Possible variable structural conformations for cyclotrimeric 1-lithio-2-t-
butyl-1,2-dihydropyridine complexes (C2 atoms also bear a hydrogen atom which has 
been omitted for clarity); b) tilting movement of the NC5 dihydropyridyl ring towards 
one of the adjacent lithium atoms resulting in a stereogenic nitrogen and a shorter (V) 
and longer (S) Li-dihydropyridyl interaction (tBu groups and H atoms have been 
omitted for clarity); c) cyclic structure with butyl groups included to emphasise 
difference between R,R,R and S,S,S enantiomers due to axial chirality. 
 
Table 3 Calculated energies of different possible configuration sets of complex 1t 
Entry Model C2 &¶ &¶¶ Absolute energy 
(kcal mol-1) 
Relative energy 
(kcal mol-1) 
1 A S S S -1240.806479 0.000 
2 A R S S -1240.804562 +1.203 
3 A R R S -1240.801927 +2.856 
4 A R R R -1240.798594 +4.948 
5 B S S S -1240.804711 +1.109 
6 B S S R -1240.806342 +0.086 
7 B R S S -1240.801909 +2.868 
8 B R S R -1240.804633 +1.158 
9 B S R S -1240.802243 +2.658 
10 B S R R -1240.804634 +1.158 
11 B R R S -1240.798526 +4.991 
12 B R R R -1240.802058 +2.774 
 
The study showed that the approximately C3 symmetric structure (entry 1 in table 3, 
for full structural parameters see SI) was the lowest energy conformation. Crucially 
however, it showed that all twelve modeled structures came within 5 kcal mol-1 of 
each other and indeed nine of the remaining eleven were less than 3 kcal mol-1 higher 
in energy than the energy minimum, entry 1. This narrow range of energies for the 
different conformations suggests the possibility that multiple conformations might be 
present in a sample and can potentially also explain why single crystals of the trimeric 
complex 1t (or indeed 2-sBuC5H5NLi, 1s, vide infra) cannot be obtained. 
 
Searching for an alternative hexane soluble 1-lithio-2-alkyl-1,2-dihydropyridine 
In order to minimize the usage of highly pyrophoric t-butyllithium in the laboratory, 
our next aim was to ascertain whether an equally reactive congener of 1t could be 
prepared using an alternative but less pyrophoric alkyl lithium reagent.38 Given that 
the n-butyl adduct 1n is hexane insoluble (and presumably polymeric) we 
immediately ruled out other straight chain alkyl groups such as those from 
commercially available methyl- or ethyllithium. The good solubility of complex 1t 
was attributed to the steric effects of the t-butyl group inhibiting polymerization and 
so we logically considered the branched i- and s-butyl isomers. Like the n-butyl 
derivative, the i-butyl complex 2-iBuC5H5NLi 1i precipitated from solution almost 
immediately, even under dilute conditions, implying that a polymeric complex akin to 
1n was being produced. 1H and 13C NMR spectroscopy in d8-THF solution confirmed 
this product to be the desired one, with the chemical shifts indicating loss of 
aromaticity and the presence of five distinct ring resonances indicating loss of 
symmetry and thus 1,2 addition of the alkyl lithium reagent. Moving to s-butyllithium, 
the resulting yellow product 1s remained in solution for a prolonged period of time, 
with a yellow microcrystalline product precipitating upon cooling to -30oC. Although 
the recrystallized material represented a fairly moderate yield of 44%, 1H NMR 
interrogation of the filtrate suggested the reaction was virtually quantitative and that 
therefore any pre-prepared solutions could be used in situ with confidence in their 
molarity for subsequent stoichiometric reactions. The filtered product appeared to 
start degrading on the filter stick upon prolonged application of dynamic vacuum, 
although if collected in an inert atmosphere after only a short period of vacuum 
application then the product appeared to have a longer lifespan. Soluble in C6D12 after 
a few seconds of gentle heating of the mixture, complex 1s displayed 1H and 13C 
NMR spectra consistent with 1,2 addition of the alkyl lithium to pyridine, specifically 
via shielding of the five pyridyl resonances consistent with loss of both aromaticity 
and symmetry (table 2). However, the presence of other small resonances indicated 
that this was not the only species present in solution, specifically four extra 
resonances were evident in the aromatic region of the spectrum indicative of 
aromaticity and more specifically a 2-substituted pyridine.  
The deterioration issue under vacuum coupled with this NMR evidence hinted that 
LiH was being extruded from complex 1s under only mild (ambient) conditions and 
that 1s is therefore potentially more reactive than its tBu isomer 1t, which, in contrast, 
is thermally robust in C6D12 solution. This conversion from the 1,2-dihydropyridyl 
complex to a substituted pyridine was monitored via 1H NMR spectroscopy over time 
(see figure 6a for full details) which confirmed that complex 1s converts cleanly to 2-
s-butylpyridine in cyclohexane at 55oC in less than a day.  
 
 Figure 6 a (top) Section of 1H NMR spectra over time of a 1s sample in C6D12 
solution showing loss of five dihydropyridyl (non-aromatic) resonances and 
concomitant growth of four 2-substituted pyridyl (aromatic) resonances and b 
(bottom) Plot of concentration of 1s (blue) and 2-s-butylpyridine (red) as a function of 
time  
To study the conversion of 1s to LiH and 2-s-butylpyridine further we repeated the 1H 
NMR study over time at a constant temperature (21oC) in the presence of the inert 
standard hexamethylbenzene to allow accurate concentration determination at each 
interval. After almost two weeks the conversion was virtually complete. A plot of 1s 
and 2-s-butylpyridine concentration versus time showed that the conversion appears 
to follow two distinct phases. The first, which occurs over a time period of 
approximately two days, behaves according to zero order kinetics. The data following 
this are then consistent with a first order process. This can perhaps be attributed to the 
preparation of Lewis donor s-butylpyridine as part of the conversion process which 
will be available to solvate the lithium centre of 1s, reducing its oligomerization to 
first dimeric (similar to complex 1t·TMEDA) and then to monomeric (similar to 
complex 1t·PMDETA) as its relative concentration increases.  
To ascertain the aggregation state of 1s in solution, we again turned to 1H DOSY 
NMR spectroscopy. Unfortunately, due to the conversion of 1s to 2-s-butylpyridine it 
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was impossible to quantify the estimated molecular weight since the resonances of the 
developing aromatic species coincided with those of the aromatic standards 1-
phenylnaphthalene (PhN) and 1,2,3,4-tetraphenylnaphthalene (TPhN) and thus 
interfered with their integration, which is necessary for the calculation of diffusion 
coefficients. However, qualitative perusal of the resulting spectrum (figure 7) 
certainly supports the suggestion that 1s is trimeric in solution since its resonances 
appear in line with those of TPhN which has a molecular weight of 432.55 (the 
molecular weight of a trimer would be 429.47). 
 
Figure 7 1H DOSY NMR spectrum of 1s in C6D12 solution at 300K containing the 
inert standards 1,2,3,4-tetraphenylnaphthalene (TPhN), 1-phenylnaphthalene (PhN) 
and tetramethylsilane (TMS). 
 
To further study the ease with which LiH is liberated from a solid sample of 1s (and 
1i for comparison) we turned to thermal volatility analysis (TVA).39 This showed 
(figure 8) that evolution of a volatile material from 1s commences close to 60oC and 
occurs over a narrower temperature range (approx. 60oC) than for 1n or 1t (both 
approximately 100oC) with a maximum pressure seen just below 110oC. In 
comparison, 1i did not start to liberate volatiles until 70oC and this liberation was not 
complete until almost 130oC. In each case there was no sign of non-condensable 
volatile products. The condensable products were identified as the appropriate 2-
butylpyridine by 1H and 13C NMR spectroscopy and their IR spectra were obtained 
(see SI). 
 
 
Figure 8 Thermal Volatility Analysis thermograms for 1s (top) and 1i (bottom). The 
blue line represents total volatile products, and the red line non-condensable volatile 
products. 
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With a hexane soluble complex in hand, we next studied its ability to operate as a 
lithium hydride transfer reagent. Mirroring our recent studies of 1-lithio-2-t-butyl-1,2-
dihydropyridine 1t for consistency and comparison, we prepared a sample of 1s in 
hexane and introduced benzophenone. After approximately 10 minutes, a white 
precipitate formed which was isolated and confirmed by 1H NMR spectroscopy as the 
anticipated lithium alkoxide LiOCH(Ph)2. A total isolated yield of 71% was 
comparable with that obtained using 1t (83%), suggesting that this synthetically safer 
sBu isomer is essentially as efficient a hydrolithiation agent as its tBu isomer. The 
marginally lower yield might be due to 1s starting to degrade partially to s-
butylpyridine prior to the addition of benzophenone. 
 
Assessing the importance of pyridine stoichiometry 
Finally, we carried out the reaction of pyridine with nBuLi in the presence of 
Me6TREN in hexane solution but this time increasing the number of pyridine 
equivalents from one to two in order to judge the importance of keeping the ratio at 
unity for the synthesis of a 1,2-dihydropyridyl complex capable of acting as a LiH 
transfer reagent. This mixture was heated for 1 hour at 50oC then allowed to cool 
slowly, resulting in a red oily product from which a small crop of crystals developed. 
These crystals were identified via X-ray crystallography to be the non-alkylated 1-
lithio-1,4-dihydropyridine complex H6C5NLi·Me6TREN, 2 (figure 9), that is the 
H[SHFWHG³DGGHG´n-butyl ligand has been replaced by a hydride anion.  
 Figure 9 Molecular structure of monomeric 1,4-dihydropyridylLi·Me6TREN (2). 
Ellipsoids are displayed at 50% probability and all hydrogen atoms except those on 
C15 are omitted for clarity. Selected bond lengths (Å) and angles (o): Li1-N1 
2.139(5); Li1-N2 2.108(4); Li1-N3 2.105(5); Li1-N4 4.604(5); Li1-N5 1.969(5); N5-
C13 1.385(3); C13-C14 1.340(4); C14-C15 1.503(4); C15-C16 1.501(4); C16-C17 
1.343(4); C17-N5 1.375(3); N1-Li1-N2, 85.2(2); N1-Li1-N3, 88.7(2); N1-Li1-N5, 
132.1(2); N2-Li1-N3, 119.2(2); N2-Li1-N5, 118.2(2); N3-Li1-N5, 110.1(2). 
 
 
Presumably, 1n·Me6TREN is formed first in situ and then an intermolecular 1,4-
addition of LiH to the extra pyridine molecule occurs to give 2 with 2-n-butylpyridine 
being the other product (equation 2). Complex 2 can be considered a monomeric 
variant of the previously reported pyridine solvate of 1-lithio-1,4-dihydropyridine 
which is dimeric in the solid state and is made in a similar fashion.8c As in 
1t·Me6TREN, the donor binds to lithium in a hypodentate K3 fashion with one arm 
free, giving lithium an overall coordination number of 4 within a distorted tetrahedral 
geometry. This hypodentate binding mode is unlikely to be purely steric in origin 
since Me6TREN has previously been shown to bind in a K4 fashion in the related 
complex 4-picolyllithium which has a virtually identical local environment around the 
anionic nitrogen atom (figure 10).19 The six membered dihydropyridyl ring of 2 is 
clearly planar [C4 lies only 0.055(3) Å outside the plane of the remaining C4N unit] 
with the shorter CD-CE bonds [1.340(4)/1.343(4) Å] and longer CE-CJ bonds 
[1.503(4)/1.501(4) Å] indicative of double and single bonds respectively. The 
hydrogen atoms at the 4-position were located and refined, confirming this carbon is 
sp3 hybridised and that the ligand is a dihydropyridyl anion. The Li-N5(pyr) distance 
[1.969(5) Å] is consistent with other crystallographically characterized monomeric, 
four-coordinate lithium secondary amides such as PMDETA-solvated lithium D-
(methylbenzyl)benzylamide [1.959(7) Å],40 lithium bis(D-methylbenzyl)amide 
[1.949(6) Å] 41 and lithium 3,6-diethoxy-2,5-dihydro-2-isopropylpyrazide [1.965(3) 
Å] 42 reported by Andrews et al., while the Li-N(Me6TREN) distances [2.105(5)-
2.139(5) Å] are longer reflecting the weaker donor acceptor nature of these 
interactions. 
 
Figure 10 molecular structures of 2 (left) and 4-picolyllithium·Me6TREN 
 
Unlike the 2-alkyl-1,2-dihydropyridyl complexes mentioned thus far (1t·donor), 2 is 
insoluble in aliphatic cyclohexane and thus its NMR spectra were collected in C6D6 
solution. These spectra confirm that mirroring the molecular structure, the 
dihydropyridyl anion is in its 1,4 isomeric form and not the 1,2.  Specifically, there 
are only three dihydropyridyl resonances of equal intensity (located at 6.50, 4.58 and 
4.36 ppm), consistent with a symmetric, non-aromatic 1,4 isomer. 13C and 7Li NMR 
spectra corroborated this regiochemistry. Although the isolated yield of 2 was low, a 
1H NMR spectrum of the filtrate confirmed that this was the exclusive lithium-
containing product, with no evidence of a 1,2 isomer. The by-product, 2-n-
butylpyridine was also clearly present along with some free uncoordinated Me6TREN. 
 
Conclusions 
This study has advanced the chemistry of 1-lithio-2-alkyl-1,2-dihydropyridines. The 
key to this progress has been to use stoichiometric amounts of pyridine in reactions 
with alkyllithium compounds as opposed to the more common usage of excess 
pyridine. Three new crystalline complexes have emerged from this study in the 1,2-
alkyl complexes 2-tBuC5H5NLi·PMDETA (1t·PMDETA) and 2-
tBuC5H5NLi·Me4AEE (1t·Me4AEE) both of which show these kinetic intermediates 
can be stabilized in monomeric form using polydentate donor supports, as well as the 
non-alkyl complex 1,4-H6C5NLi·Me6TREN, 2, which demonstrate that 1,2-alkyl 
isomers can react with any available excess pyridine to generate thermodynamic lithio 
1,4-dihydropyridines and 2-alkylpyridine byproducts. The study also brings to the 
fore the subtle effect the alkyl substituent can have on the solubility of the complex, 
with the t-butyl and s-butyl isomers showing excellent solubility in aliphatic 
hydrocarbon solvents; whereas the n-butyl and i-butyl isomers are essentially 
insoluble. These differences appear to reflect the different aggregation states involved 
with the former pair molecular and the latter pair probably polymeric. Though the 
hydrolithiation properties of these new isolated lithio dihydropyridines have been 
touched upon here, the fact that these complexes are easily synthesized and (some) 
exhibit excellent solubility, suggest their application as transporters of molecular LiH 
will increase in the future. 
Experimental 
General experimental 
All reactions and manipulations were carried out under a protective dry argon 
atmosphere using standard Schlenk techniques. Products were isolated and NMR 
samples pre-prepared in an argon-filled glove box. Hexane and THF were dried by 
heating to reflux over sodium-benzophenone and distilled under nitrogen prior to use. 
Me6TREN was prepared according to a literature method.43 TMEDA, Me4AEE and 
PMDETA were distilled over CaH2 and stored over 4 Å molecular sieves prior to use. 
Pyridine (anhydrous, 99.8%), benzophenone, nBuLi (1.6 M in hexanes), iBuLi (1.7 M 
in heptane), sBuLi (1.4 M in cyclohexane), and tBuLi (1.7 M in pentane) were 
purchased from Aldrich and used as received. NMR spectra were recorded on a 
Bruker AVANCE 400 NMR spectrometer, operating at 400.13 MHz for 1H, 155.50 
MHz for 7Li and 100.62 MHz for 13C. All 13C spectra were proton decoupled. 1H and 
13C spectra were referenced to the appropriate solvent signal and 7Li spectra were 
referenced against LiCl in D2O at 0.00 ppm. Elemental analyses were carried out on a 
Perkin-Elmer 2400 elemental analyser. Satisfactory elemental analyses could not be 
obtained for 1s (due to its high reactivity and conversion into s-butylpyridine and LiH, 
vide supra), 1i (presumably as a result of its sensitive nature) and 2 (which is 
predominantly an oil). 1H NMR spectra of all new complexes are therefore provided 
in the SI as an alternative proof of purity. 
 
DOSY NMR Spectroscopy 
Diffusion-Ordered Spectroscopy (DOSY) NMR experiments were performed on a 
Bruker AVANCE 400 NMR spectrometer operating at 400.13 MHz for proton 
resonance under TopSpin (version 2.0, Bruker Biospin, Karslruhe) and equipped with 
a BBFO-z-atm probe with actively shielded z-gradient coil capable of delivering a 
maximum gradient strength of 54 Gcm-1. Diffusion-ordered NMR data were acquired 
using the Bruker pulse program dstegp3s employing a double stimulated echo with 
three spoiling gradients. Sine-shaped gradient pulses were used with a duration of 4 
ms together with a diffusion period of 100 ms. Gradient recovery delays of 200 Ps 
followed the application of each gradient pulse. Data were systematically 
accumulated by linearly varying the diffusion encoding gradients over a range of 2% 
to 95% of maximum for 64 gradient increment values. The signal decay dimension on 
the pseudo-2D data was generated by Fourier transformation of the time-domain data. 
DOSY plots were generated by use of the DOSY processing module of TopSpin. 
Parameters were optimized empirically to find the best quality of data for presentation 
purposes. Diffusion coefficients were calculated by fitting intensity data to the 
Stejskal-Tanner expression. 
Samples were prepared by introducing the desired complex (0.1 mmol) to a NMR 
tube containing 1,2,3,4-tetraphenylnaphthalene (TPhN, 15 mg), 1-phenylnaphthalene 
(PhN, 13.2 PL) and tetramethylsilane (TMS, 19.1 PL) as inert internal reference 
standards in 0.5 mL of the desired solvent for a concentration of 0.2 mol/l. The 1H 
DOSY NMR data were recorded at 300 K. From the diffusion coefficients of the 
internal standards, linear calibration graphs were obtained by plotting logD versus 
logFW. Using the diffusion coefficients for the signals corresponding to the species 
under study an estimate of FW in solution was obtained. 
 
X-ray crystallography 
Crystallographic data were collected on Oxford Diffraction instruments with Mo or 
Cu KD radiation. Structures were solved using SHELXS-97,44 while refinement was 
carried out on F2 against all independent reflections by the full-matrix least-squares 
method using the SHELXL-97 program.44 All non-hydrogen atoms were refined using 
anisotropic thermal parameters. Selected crystallographic details and refinement 
details are provided in table 4. 1t·Me4AEE  was treated as a twin. A hklf 5 formatted 
reflection file was created with the two twin components related by matrix -1 0 -0.03 
0 -1 0 0 0 1. The twin ratio refined to 0.618(4):0.382(4). CCDC-1061251 ± CCDC-
1061253 contain the supplementary crystallographic data for this structure. This data 
can be obtained free of charge from the Cambridge Crystallographic Data Centre via 
www.ccdc.cam.ac.uk/data_request/cif.  
Table 4 Crystallographic data and refinement details for complexes 1t·PMDETA, 
1t·Me4AEE and 2. 
Compound 1t·PMDETA 1t·Me4AEE 2 
Formula C18H37N4Li C17H34N3LiO C17H36N5Li 
Formula weight 316.46 303.41 314.45 
Crystal system monoclinic monoclinic orthorhombic 
Space group P 21/c P 21/c P c a 21 
Wavelength/Å 0.71073 0.71073 1.54180 
a/Å 9.1578(2) 12.6639(19) 13.4284(4) 
b/Å 13.9331(3) 9.5511(16) 10.5694(3) 
c/Å 16.2095(4) 16.073(3) 14.1379(4) 
ȕ 105.925(2) 90.848(15) 90 
Volume/Å3 1988.90(8) 1943.8(6) 2006.6(1) 
Z 4 4 4 
Reflns. collected 39810 4860a 7712 
Unique reflns. 4732 4860a 3270 
Rint 0.0469 0.0573 0.0218 
Obs. Reflns. [I>2V(I)] 3410 2278 3047 
Goodness of fit 1.017 1.018 1.046 
R[F2 > 2ı], F 0.0492 0.0937 0.0570 
Rw (all data), F2 0.1152 0.2486 0.1600 
Largest diff. peak/hole e/ Å-3 0.277/-0.178 0.366/-0.92 0.371/-0.187 
a Twinned sample refined against a hklf 5 formatted reflection file. 
Theoretical calculations 
DFT calculations were performed using the Gaussian45 03 package using the 
B3LYP46 density functional and the 6-311(d, p)47 basis set. After each geometry 
optimization a frequency analysis was performed. The energy values quoted include 
the zero point energy contribution. 
 
Synthesis of 2-tBu(C5H5N)Li·PMDETA (1t·PMDETA) 
A sample of 1t (143 mg, 1 mmol) was added to a Schlenk flask and dissolved in 
hexane (5 mL) by gently warming with a heat gun for a few seconds. PMDETA (0.21 
mL, 1 mmol) was added via syringe producing a thick oil. THF was slowly added 
dropwise with stirring until a homogeneous yellow solution was obtained. Yellow 
crystals formed after standing the solution at -30oC for one week (yield 0.211 g, 
67 %). 
1H NMR (400.1 MHz, C6D12, 300 K): G6.56 (1H, d, 3JH-H = 4.70 Hz, H6), 5.85 (1H, t, 
3JH-H = 5.82 Hz, H4), 4.07 (1H, t, 3JH-H = 5.29 Hz, H5), 3.95 (1H, br s, H3), 3.54 (1H, 
br d, 3JH-H = 4.56 Hz, H2), 2.46 (4H, br s, 2 x CH2 PMDETA), 2.38 (7H, br s, CH3 + 
2 x CH2 PMDETA), 2.32 (12H, s, 4 x Me PMDETA), 0.87 ppm (9H, s, CH3). 
13C NMR (100.6 MHz, C6D12, 300 K): G 150.8 (C6), 128.8 (C4), 95.2 (C3), 87.4 (C5), 
69.5 (C2), 58.1 (CH3 PMDETA), 55.0 (CH2 PMDETA), 46.0 (4 x Me PMDETA), 
45.2 (CH2 PMDETA), 41.1 ( 7 ppm (CH3). 
7Li NMR (155.5 MHz, C6D12, 300 K): G 0.82 ppm. 
Elemental analysis (%) for C18H37N4Li: calcd: C 68.31, H 11.78, N 17.70; found: C 
67.64, H 11.85, N 17.33. 
 
Synthesis of 2-tBu(C5H5N)Li·Me4AEE (1t·Me4AEE) 
A sample of 1t (143 mg, 1 mmol) was added to a Schlenk flask and dissolved in 
hexane (5 mL) by gently warming with a heat gun for a few seconds. Me4AEE (0.19 
mL, 1 mmol) was added via syringe producing a thick oil. THF was slowly added 
dropwise with stirring until a homogeneous yellow solution was obtained. Yellow 
crystals formed after standing the solution at -30oC for one week (yield 0.097 g, 
32 %). 
1H NMR (400.1 MHz, C6D12, 300 K): G6.62 (1H, d, 3JH-H = 5.60 Hz, H6), 5.92 (1H, 
dq, 3JH-H = 5.60, 1.23 Hz, H4), 4.36 (1H, dt, 3JH-H = 5.60, 1.34 Hz, H5), 4.18 (1H, dd, 
3JH-H = 4.89 Hz, H3), 3.55 (4H, t, 3JH-H = 5.52 Hz, O-CH2 Me4AEE), 3.46 (1H, d, 3JH-
H = 5.00 Hz, H2), 2.50 (4H, t, 3JH-H = 5.55 Hz, CH2-N Me4AEE), 2.24 (s, 12H, N-CH3 
Me4AEE), 0.84 ppm (s, 9H, CH3). 
13C NMR (100.6 MHz, C6D12, 300 K): G 151.0 (C6), 128.2 (C4), 97.2 (C3), 91.6 (C5), 
69.4 (O-CH2 Me4AEE), 66.9 (C2), 59.4 (CH2-N Me4AEE), 45.8 (N-CH3 Me4AEE), 
40.9 ( 3). 
7Li NMR (155.5 MHz, C6D12, 300 K): G 0.34 ppm. 
Elemental analysis (%) for C17H34N3LiO: calcd: C 67.29, H 11.29, N 13.85; found: C 
66.67, H 11.22, N 14.10. 
 
Synthesis of 2-tBu(C5H5N)Li·TMEDA (1t·TMEDA) 
A sample of 1t (143 mg, 1 mmol) was added to a Schlenk flask and dissolved in 
hexane (5 mL) by gently warming with a heat gun for a few seconds. TMEDA (0.15 
mL, 1 mmol) was added via syringe giving a homogeneous yellow solution. Orange 
crystals formed after standing the solution at -30oC for one week (yield 0.212 g, 
82 %). 
1H NMR (400.1 MHz, C6D12, 300 K): G6.70 (1H, d, 3JH-H = 5.19 Hz, H6), 6.04 (1H, t, 
3JH-H = 5.54 Hz, H4), 4.58 (1H, t, 3JH-H = 5.19 Hz, H5), 4.07 (1H, m, 3JH-H = 5.19 Hz, 
H3), 3.30 (1H, d, 3JH-H = 4.67 Hz, H2), 2.34 (4H, s, CH2 TMEDA), 2.26 (12H, s, Me 
TMEDA), 0.82 ppm (9H, s, CH3). 
13C NMR (100.6 MHz, C6D12, 300 K): G 151.3 (C6), 127.0 (C4), 94.4 (C3), 93.8 (C5), 
66.2 (C2), 58.9 (CH2 TMEDA), 46.8 (Me TMEDA), 41.6 
( 6.0 ppm (CH3). 
7Li NMR (155.5 MHz, C6D12, 300 K): G -1.67 ppm. 
 
Synthesis of 2-iBu(C5H5N)Li (1i) 
Pyridine (0.40 mL, 5 mmol) was added to a Schlenk flask containing hexane (10 mL). 
iBuLi (3.12 mL, 1.6 M in hexane, 5 mmol) was added via syringe, giving a yellow 
solution. A pale yellow precipitate formed almost immediately after the addition of 
iBuLi which was filtered and collected (yield 0.66 g, 4.62 mmol, 92 %).  
1H NMR (400.1 MHz, d8-THF, 300 K): G6.54 (1H, d, 3JH-H = 5.39 Hz, H6), 5.71 (1H, 
t, 3JH-H = 5.59 Hz, H4), 4.25 (1H, t, 3JH-H = 5.49 Hz, H5), 3.97 (1H, t, 3JH-H = 5.59 Hz, 
H3), 3.63 (1H, quin, 3JH-H = 4.51 Hz, H2), 1.84 (2H, m, 3JH-H = 5.30 Hz, D-CH2), 1.29 
(1H, br s, CH), 0.83 ppm (6H, d, 3JH-H = 6.57 Hz, CH3). 
13C NMR (100.6 MHz, d8-THF, 300 K): G 150.0 (C6), 126.5 (C4), 95.1 (C3), 89.2 
(C5), 53.3 (C2), 43.9 (D-CH2), 23.8 (CH3), 22.8 ppm (CH). 
7Li NMR (155.5 MHz, d8-THF, 300 K): G 0.29 ppm. 
 
Synthesis of 2-sBu(C5H5N)Li (1s) 
Pyridine (1.12 mL, 14 mmol) was added to a Schlenk flask containing hexane (10 
mL). sBuLi (10 mL, 1.4 M in hexane, 14 mmol) was added via syringe, giving a 
yellow solution. A pale yellow precipitate formed upon cooling the solution to -30oC 
which was filtered and collected (yield 0.88 g, 6.16 mmol, 44 %).  
1H NMR (400.1 MHz, C6D12, 300 K): G6.73 (1H, d, 3JH-H = 5.25 Hz, H6), 6.04 (1H, 
m, H4), 5.08 (1H, br t, 3JH-H = 5.25 Hz, H5), 4.40 (1H, br m, H3), 3.10 (1H, br m, H2), 
1.55 (2H, m, D-CH + 1 from CH2), 0.97 (1H, m, 1 from CH2), 0.85 (3H, m, CH3), 
0.77 ppm (3H, m, CH3). 
13C NMR (100.6 MHz, C6D12, 300 K): G 147.7 (C6), 125.7 (C4), 96.6 (C5), 95.1 (C3), 
60.6 (C2), 37.2 (CH), 24.8 (CH2), 15.0 (CH3), 11.4 ppm (CH3). 
7Li NMR (155.5 MHz, C6D12, 300 K): G -1.97 ppm. 
 
Synthesis of 1,4-dihydropyridylLiȈMe6TREN (2) 
Pyridine (0.32 mL, 4 mmol) and Me6TREN (0.52 mL, 2 mmol) were added to a 
Schlenk flask containing hexane (5mL). nBuLi (1.25 mL, 1.6 M in hexane, 2 mmol) 
was added via syringe, giving an orange solution. This solution was heated at 50oC 
for one hour then allowed to slowly cool, depositing an orange-red oil which 
contained a small crop of crystalline material. The oil and solvent mixture was 
decanted off and the sticky crystals dried and collected (yield 0.121g, 19 %). 
1H NMR (400.1 MHz, C6D6, 300 K): G6.50 (2H, d, 3JH-H = 7.27 Hz, H2), 4.56 (2H, m, 
H3), 4.38 (2H, br t, H4), 2.01-1.91 ppm (br s with shoulder, 30H, Me6TREN). 
13C NMR (100.6 MHz, C6D6, 300 K): G 143.5 (C2), 89.4 (C3), 57.5 (CH2 Me6TREN), 
51.9 (CH2 Me6TREN), 45.6 (Me Me6TREN), 27.9 ppm (C4). 
7Li NMR (155.5 MHz, C6D6, 300 K): G 0.68 ppm. 
 
2-i-butylpyridine 
1H NMR (400.1 MHz, CDCl3, 300 K): G8.53 (1H, br s, H6), 7.59 (1H, t, 3JH-H = 7.64 
Hz, H4), 7.11 (2H, br t, H3 + H5), 2.66 (2H, d, 3JH-H = 7.30 Hz, D-CH2), 2.11 (1H, m, 
3JH-H = 6.87 Hz,E-CH), 0.93 ppm (6H, d, 3JH-H = 6.61 Hz, CH3). 
13C NMR (400.1 MHz, CDCl3, 300 K): G 2  
 (C4)  (C3)  (C5)  
(CH2)  (CH)  (CH3)  
 
2-s-butylpyridine 
1H NMR (400.1 MHz, CDCl3, 300 K): G8.56 (1H, d, 3JH-H = 5.05 Hz, H6), 7.65 (1H, 
t, 3JH-H = 7.46 Hz, H4), 7.15 (2H, m, H3 + H5), 2.87 (1H, m, 3JH-H = 6.80 Hz, D-CH), 
1.78 (1H, m, 3JH-H = 7.46 Hz,CH2), 1.65 (1H, m, 3JH-H = 7.02 Hz,CH2), 1.29 (3H, d, 
3JH-H = 7.02 Hz, H3), 0.87 ppm (3H, t, 3JH-H = 7.46 Hz, CH2CH3). 
13C NMR (400.1 MHz, CDCl3, 300 K): G 5 7 7 9 
4 1 3 7 2 8 
4 (CH2 19 8 (CHCH3) 2CH3)  
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